logo
Select company
Select metric
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ -35.97M$ 00
3/31/2025$ -38.02M$ 00
12/31/2024$ -77.14M$ 00
9/30/2024$ -263.83M$ 00
6/30/2024$ -247.38M$ 1.27M-194.32
3/31/2024$ -271.85M$ 2.02M-134.24
12/31/2023$ -235.88M$ 2.83M-83.26
9/30/2023$ -32.81M$ 3.64M-9.01
6/30/2023$ -32.49M$ 3.17M-10.25
3/31/2023$ -12.54M$ 3.13M-4
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Coverage stands at -56.99.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Int. Coverage has been -33.83.
  • The median Int. Coverage for CARTESIAN THERAPEUTICS INC during this period was -11.22
  • CARTESIAN THERAPEUTICS INC reached its highest Int. Coverage over the past 5 years at 17.77.
  • The lowest Int. Coverage recorded by CARTESIAN THERAPEUTICS INC in the same timeframe -194.32

CARTESIAN THERAPEUTICS INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
HUMA : HUMACYTE INC -4.59NWBO : NORTHWEST BIOTHERAPEUTICS INC -9.29MREO : MEREO BIOPHARMA GROUP PLC -54.02INBX : INHIBRX BIOSCIENCES INC -27.08CRDF : CARDIFF ONCOLOGY INC -BTAI : BIOXCEL THERAPEUTICS INC -2.18CATX : PERSPECTIVE THERAPEUTICS INC -398.38ADVM : ADVERUM BIOTECHNOLOGIES INC -SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -LSTA : LISATA THERAPEUTICS INC -

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for CARTESIAN THERAPEUTICS INC is calculated as follows: EBIT [ $ -67.14M ] / Int. Exp. [ $ 1.18M ]
(=) Int. Coverage [ -56.99 ]

RNAC - Interest Coverage, Last 5 years

-194.32

Minimum

Jun 30, 2024

17.77

Maximum

Jun 30, 2022

-33.83

Average

-11.22

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.16 with a standard deviation of 8.41.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.36K
min-25.4
max28.75
average2.16
median2.09
std8.41